Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Zolpidem

A hypnotic of the imidazopyridine family, one of the Z-drugs, developed in France and in use in Europe since 1988 (in the United States since 1992) for the short-term treatment of insomnia. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?In some patients in a vegetative state after brain injury a paradoxical effect has been observed: instead of sedating, it seems to temporarily reawaken some functions. The phenomenon is still being studied.

ZolpidemGo to the active ingredient →
ZolpidemActive ingredientZolpidemCat. No. P-Z024-001CAS 82626-48-0
Zolpidem-d6Isotopically labelledZolpidem-d6Cat. No. P-Z024-012CAS 959605-90-4
Zolpidem IVImpurityZolpidem IVCat. No. P-Z024-022CAS 768398-03-4

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.